274 related articles for article (PubMed ID: 19846958)
1. Cancer nanotargeted radiopharmaceuticals for tumor imaging and therapy.
Ting G; Chang CH; Wang HE
Anticancer Res; 2009 Oct; 29(10):4107-18. PubMed ID: 19846958
[TBL] [Abstract][Full Text] [Related]
2. Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy.
Ting G; Chang CH; Wang HE; Lee TW
J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20811605
[TBL] [Abstract][Full Text] [Related]
3. Nanocarriers for nuclear imaging and radiotherapy of cancer.
Mitra A; Nan A; Line BR; Ghandehari H
Curr Pharm Des; 2006; 12(36):4729-49. PubMed ID: 17168775
[TBL] [Abstract][Full Text] [Related]
4. Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer.
Hamoudeh M; Kamleh MA; Diab R; Fessi H
Adv Drug Deliv Rev; 2008 Sep; 60(12):1329-46. PubMed ID: 18562040
[TBL] [Abstract][Full Text] [Related]
5. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions.
Farzin L; Sheibani S; Moassesi ME; Shamsipur M
J Biomed Mater Res A; 2019 Jan; 107(1):251-285. PubMed ID: 30358098
[TBL] [Abstract][Full Text] [Related]
6. Radiolabelled nanoparticles: novel classification of radiopharmaceuticals for molecular imaging of cancer.
Mirshojaei SF; Ahmadi A; Morales-Avila E; Ortiz-Reynoso M; Reyes-Perez H
J Drug Target; 2016; 24(2):91-101. PubMed ID: 26061297
[TBL] [Abstract][Full Text] [Related]
7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional radiolabeled nanoparticles: strategies and novel classification of radiopharmaceuticals for cancer treatment.
Enrique MA; Mariana OR; Mirshojaei SF; Ahmadi A
J Drug Target; 2015 Apr; 23(3):191-201. PubMed ID: 25534010
[TBL] [Abstract][Full Text] [Related]
9. Molecular nanomedicine towards cancer: ¹¹¹In-labeled nanoparticles.
Psimadas D; Georgoulias P; Valotassiou V; Loudos G
J Pharm Sci; 2012 Jul; 101(7):2271-80. PubMed ID: 22488174
[TBL] [Abstract][Full Text] [Related]
10. Translating Research for the Radiotheranostics of Nanotargeted
Chang CH; Chang MC; Chang YJ; Chen LC; Lee TW; Ting G
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918011
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
Raj R; Mongia P; Kumar Sahu S; Ram A
Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
[TBL] [Abstract][Full Text] [Related]
12. Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges.
Salih S; Alkatheeri A; Alomaim W; Elliyanti A
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014472
[TBL] [Abstract][Full Text] [Related]
13. Biological carrier molecules of radiopharmaceuticals for molecular cancer imaging and targeted cancer therapy.
Aerts A; Impens NR; Gijs M; D'Huyvetter M; Vanmarcke H; Ponsard B; Lahoutte T; Luxen A; Baatout S
Curr Pharm Des; 2014; 20(32):5218-44. PubMed ID: 24606796
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnology platforms and physiological challenges for cancer therapeutics.
Kim KY
Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic nanocarriers for sentinel lymph node imaging.
Jain R; Dandekar P; Patravale V
J Control Release; 2009 Sep; 138(2):90-102. PubMed ID: 19445982
[TBL] [Abstract][Full Text] [Related]
16. Dendrimers as Innovative Radiopharmaceuticals in Cancer Radionanotherapy.
Liko F; Hindré F; Fernandez-Megia E
Biomacromolecules; 2016 Oct; 17(10):3103-3114. PubMed ID: 27608327
[TBL] [Abstract][Full Text] [Related]
17. Tumor imaging and therapy using radiolabeled somatostatin analogues.
de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
[TBL] [Abstract][Full Text] [Related]
18. Preclinical in vivo cancer, straightway to patients?
de Jong M; Mather S; Maina T
Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):145-152. PubMed ID: 28347131
[TBL] [Abstract][Full Text] [Related]
19. The role of preclinical models in radiopharmaceutical therapy.
Sgouros G; Hobbs RF; Abou DS
Am Soc Clin Oncol Educ Book; 2014; ():e121-5. PubMed ID: 24857091
[TBL] [Abstract][Full Text] [Related]
20. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.
Yang F; Jin C; Subedi S; Lee CL; Wang Q; Jiang Y; Li J; Di Y; Fu D
Cancer Treat Rev; 2012 Oct; 38(6):566-79. PubMed ID: 22655679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
